Used to quantitatively measure total Matrix Metalloproteinase-13 (MMP-13) levels in human biological samples such as serum, plasma, or tissue culture supernatants. This ELISA kit is widely applied in research related to tissue remodeling, osteoarthritis, rheumatoid arthritis, cancer progression, and other conditions involving extracellular matrix degradation. It enables researchers to assess MMP-13 expression in disease states and evaluate the effectiveness of therapeutic agents targeting matrix degradation pathways. The assay is valuable in both clinical research and drug development settings where precise detection of MMP-13 concentration is required.